659 filings
Page 23 of 33
8-K
2eszmrdspxlvgds
26 Jun 09
OncoGenex Pharmaceuticals Files Shelf Registration Statement
12:00am
8-K
5witj57u0m0pepr5n
24 Jun 09
Regulation FD Disclosure
12:00am
8-K
flo 47op62d
3 Jun 09
OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer
12:00am
8-K
b0w1fe40r0hdmno
18 May 09
Regulation FD Disclosure
12:00am
8-K
s1cj2cjxt8wz
7 May 09
Results of Operations and Financial Condition
12:00am
8-K
hnub ipwzgmzpwa4
29 Apr 09
Oncogenex Receives Confirmation from Fda on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer
12:00am
CT ORDER
dl06i
15 Apr 09
Confidential treatment order
12:00am
S-8 POS
newkx6wot8
8 Apr 09
Registration of securities for employees (post-effective amendment)
12:00am
8-K
tweu0g0i
2 Apr 09
Entry into a Material Definitive Agreement
12:00am
8-K
i73 l0kwbo8u
11 Mar 09
OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009
12:00am
8-K
gl5c93p7
9 Mar 09
Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
12:00am
8-K
qlwkj63 0c
17 Feb 09
Termination of a Material Definitive Agreement
12:00am
8-K
jxsg2bu1xib 48y8qaae
5 Feb 09
OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer
12:00am
8-K
w15dblvx3yt9
18 Dec 08
Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
12:00am
EFFECT
cawouq5m
8 Dec 08
Notice of effectiveness
12:00am
EFFECT
a0dnt8hv1108 w5e
8 Dec 08
Notice of effectiveness
12:00am